![Gerd Auffarth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/06/2026
Gerd U.
Auffarth is currently Chief Executive Officer at Steinbeis-transferzentrum.
Since 2011, the Chairman of the Ophthalmology Department at Ruprecht-Karls-Universität Heidelberg.
Director at The European Society of Cataract & Refractive Surgeons since 2005.
Independent Director at Outlook Therapeutics, Inc. since 2020.
Director at International Vision Correction Research Centre since 2006.
Director at David J Apple International Laboratory For Ocular Pathology since 2012.
Director at German Ophthalmological Society since 2012.
President at Deutschsprachige Gesellschaft Fur Intraokularlinsen since 2012.
Former Independent Director at Presbia PLC.
Education includes doctorates from RWTH Aachen University (1990) and Ruprecht-Karls-Universität Heidelberg.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Director/Miembro de la Junta | 20/04/2020 |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/04/2011 |
International Vision Correction Research Centre | Director/Miembro de la Junta | 01/08/2006 |
The European Society of Cataract & Refractive Surgeons
 The European Society of Cataract & Refractive Surgeons Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for cataract and refractive surgeons | Director/Miembro de la Junta | 01/09/2005 |
David J Apple International Laboratory For Ocular Pathology | Director/Miembro de la Junta | 01/06/2012 |
German Ophthalmological Society | Director/Miembro de la Junta | 01/09/2012 |
Steinbeis-transferzentrum | Director Ejecutivo | - |
Deutschsprachige Gesellschaft Fur Intraokularlinsen | Presidente | 01/03/2012 |
| Empresas | Cargo | Fin |
|---|---|---|
| PRESBIA PLC | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
RWTH Aachen University
 RWTH Aachen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The European Society of Cataract & Refractive Surgeons
The European Society of Cataract & Refractive Surgeons Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for cataract and refractive surgeons | Commercial Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Steinbeis-transferzentrum | |
Presbia PLC
 Presbia PLC Medical SpecialtiesHealth Technology Develops, manufactures and commercializes Presbia Flexivue Microlens | Health Technology |
International Vision Correction Research Centre | |
David J Apple International Laboratory For Ocular Pathology | |
German Ophthalmological Society | |
Deutschsprachige Gesellschaft Fur Intraokularlinsen |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
